Evome Medical Technologies (Evome Medical Technologies) Change In Receivables : $-1.43 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Change In Receivables?

Evome Medical Technologies's change in receivables for the quarter that ended in Dec. 2023 was $0.97 Mil. It means Evome Medical Technologies's Accounts Receivable declined by $0.97 Mil from Sep. 2023 to Dec. 2023 .

Evome Medical Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $-1.42 Mil. It means Evome Medical Technologies's Accounts Receivable increased by $1.42 Mil from Feb. 2022 to Dec. 2023 .

Evome Medical Technologies's Accounts Receivable for the quarter that ended in Dec. 2023 was $5.82 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Evome Medical Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 45.29.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Evome Medical Technologies's liquidation value for the three months ended in Dec. 2023 was $-24.12 Mil.

Evome Medical Technologies Change In Receivables Historical Data

The historical data trend for Evome Medical Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Change In Receivables Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Change In Receivables

Get a 7-Day Free Trial

2.15

0.36

-1.63

-1.42

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															0.91	-0.84	-2.41	0.84	0.97

Evome Medical Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.43 Mil.

Evome Medical Technologies (OTCPK:LNDZF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Evome Medical Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	5.817	/	11.719	*	91
=	45.29

2. In Ben Graham's calculation of liquidation value, Evome Medical Technologies's accounts receivable are only considered to be worth 75% of book value:

Evome Medical Technologies's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.685	-	32.986	+	0.75 * 5.817	+	0.5 * 7.635
=	-24.12

Evome Medical Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.